135 related articles for article (PubMed ID: 22127889)
1. Models hosts for the study of oral candidiasis.
Junqueira JC
Adv Exp Med Biol; 2012; 710():95-105. PubMed ID: 22127889
[TBL] [Abstract][Full Text] [Related]
2. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.
Kobayashi-Sakamoto M; Tamai R; Isogai E; Kiyoura Y
Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742
[TBL] [Abstract][Full Text] [Related]
5. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
[TBL] [Abstract][Full Text] [Related]
6. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
Kong EF; Kucharíková S; Van Dijck P; Peters BM; Shirtliff ME; Jabra-Rizk MA
Infect Immun; 2015 Feb; 83(2):604-13. PubMed ID: 25422264
[TBL] [Abstract][Full Text] [Related]
8. New model of oropharyngeal candidiasis in mice.
Kamai Y; Kubota M; Kamai Y; Hosokawa T; Fukuoka T; Filler SG
Antimicrob Agents Chemother; 2001 Nov; 45(11):3195-7. PubMed ID: 11600377
[TBL] [Abstract][Full Text] [Related]
9. N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis.
Ishijima SA; Hayama K; Takahashi M; Holmes AR; Cannon RD; Abe S
Med Mycol; 2012 Apr; 50(3):252-8. PubMed ID: 21859389
[TBL] [Abstract][Full Text] [Related]
10. Pathological analysis of the Candida albicans-infected tongue tissues of a murine oral candidiasis model in the early infection stage.
Okada M; Hisajima T; Ishibashi H; Miyasaka T; Abe S; Satoh T
Arch Oral Biol; 2013 Apr; 58(4):444-50. PubMed ID: 23092606
[TBL] [Abstract][Full Text] [Related]
11. Recent mouse and rat methods for the study of experimental oral candidiasis.
Costa AC; Pereira CA; Junqueira JC; Jorge AO
Virulence; 2013 Jul; 4(5):391-9. PubMed ID: 23715031
[TBL] [Abstract][Full Text] [Related]
12. Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.
Wang L; Wang C; Mei H; Shen Y; Lv G; Zeng R; Zhan P; Li D; Liu W
Mycopathologia; 2016 Feb; 181(1-2):29-39. PubMed ID: 26404163
[TBL] [Abstract][Full Text] [Related]
13. Persistent colonization of Candida albicans yeast on the tongue in NOD/SCID.e2f1-/- mice.
Arai T; Kinoshita Y; Senpuku H
J Infect Chemother; 2015 May; 21(5):370-5. PubMed ID: 25640531
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of human saliva on experimental murine oral candidiasis.
Kamagata-Kiyoura Y; Abe S; Yamaguchi H; Nitta T
J Infect Chemother; 2004 Aug; 10(4):253-5. PubMed ID: 15365870
[TBL] [Abstract][Full Text] [Related]
15. Invasion process of Candida albicans to tongue surface in early stages of experimental murine oral candidiasis.
Hisajima T; Ishibashi H; Yamada T; Nishiyama Y; Yamaguchi H; Funakoshi K; Abe S
Med Mycol; 2008 Nov; 46(7):697-704. PubMed ID: 18608936
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral inoculation of Candida albicans in tetracycline-treated rats.
Russell C; Jones JH
J Med Microbiol; 1973 Aug; 6(3):275-9. PubMed ID: 4580060
[No Abstract] [Full Text] [Related]
17. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Hayama K; Ishibashi H; Ishijima SA; Niimi K; Tansho S; Ono Y; Monk BC; Holmes AR; Harding DR; Cannon RD; Abe S
FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
[TBL] [Abstract][Full Text] [Related]
18. Experimental in Vivo Models of Candidiasis.
Segal E; Frenkel M
J Fungi (Basel); 2018 Feb; 4(1):. PubMed ID: 29415485
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
[TBL] [Abstract][Full Text] [Related]
20. Experimental candidosis and recovery of Candida albicans from the oral cavity of ovariectomized rats.
Junqueira JC; Colombo CE; Martins Jda S; Koga Ito CY; Carvalho YR; Jorge AO
Microbiol Immunol; 2005; 49(3):199-207. PubMed ID: 15781993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
